Fundraising Fox

Nilay Thakar

Investor

Principal at ARCH Venture Partners

United States

Writes $50K – $150M checks Β· typically $25M

Experience

  1. ARCH Venture PartnersPrincipalcurrent2017 β€” presentBoston, Massachusetts, United States
  2. Skylark BioCo-Founder and Head of BDcurrent2021 β€” presentCambridge, Massachusetts, United States
  3. Lifordi Immunotherapeutics, Inc.Board Observercurrent2023 β€” present
  4. Arbor BiotechnologiesBoard Observercurrent2021 β€” presentBoston, Massachusetts, United States
  5. Volastra TherapeuticsBoard Observercurrent2022 β€” present
  6. SonoTheraBoard Observercurrent2022 β€” present
  7. Doppler BioBoard Observer2023 β€” 2025
  8. hC Bioscience, Inc.Board Observer2022 β€” 2025
  9. International Society for Stem Cell ResearchCommittee Member - Industry2019 β€” 2023
  10. Australian Institute for Bioengineering and Nanotechnology AIBNGeneral Manager - Stem Cells Ltd2014 β€” 2016Greater Brisbane Area
  11. The Australian Academy of ScienceAdvisor - Theo Murphy High Flyers Think Tank2015 β€” 2016
  12. Dendright Pty LimitedCommercialization Analyst Intern2013Greater Brisbane Area

Education

  1. The University of Chicago Booth School of BusinessMaster of Business Administration (M.B.A.)
  2. The University of QueenslandDoctor of Philosophy (Ph.D.), Stem Cell Biology
  3. The University of QueenslandBachelor of Science Honours Class 1, Biochemistry

Skills & more

Languages English Β· Gujarati Β· Hindi

From Nilay's professional profile.

Same school

Shared employers

Colleagues at ARCH Venture Partners